Lipid Messengers as Targets for Antiangiogenic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|16|1615-1626

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.16, 2001-11, pp. : 1615-1626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 27-37

Bentham Science Publishers

Access to resources Recommend Favorite

Angiopoietin/Tie receptor system: emerging targets for therapeutic angiogenesis and anti-angiogenic therapy

By Siemeister G.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. : 323-332

Informa Healthcare

Access to resources Recommend Favorite

Novel Anti-Angiogenic Compounds for Application in Tumor Therapy -COP9 Signalosome-Associated Kinases as Possible Targets

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 5, 2008-05 ,pp. : 421-428

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Research on Antiangiogenic Therapy

By Kuiper R.A.J.   Schellens J.H.M.   Blijham G.H.   Beijnen J.H.   Voest E.E.  

Pharmacological Research, Vol. 37, Iss. 1, 1998-01 ,pp. : 1-16

Academic Press

Access to resources Recommend Favorite